These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 7596934

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ, Lees KR, Reid JL.
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [Abstract] [Full Text] [Related]

  • 4. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI.
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [Abstract] [Full Text] [Related]

  • 5. Comparison of captopril and enalapril in patients with severe chronic heart failure.
    Packer M, Lee WH, Yushak M, Medina N.
    N Engl J Med; 1986 Oct 02; 315(14):847-53. PubMed ID: 3018566
    [Abstract] [Full Text] [Related]

  • 6. [Enalapril versus captopril in heart failure--effect on blood pressure and kidney function].
    Osterziel KJ, Dietz R.
    Z Kardiol; 1991 Oct 02; 80 Suppl 2():28-34. PubMed ID: 2024541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [24-hour blood pressure and renal function in cardiac failure during the titration phase of captopril and enalapril].
    Osterziel KJ, Dietz R, Abushi A, Kübler W.
    Z Kardiol; 1990 Nov 02; 79(11):742-7. PubMed ID: 2278166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.
    Packer M, Lee WH, Kessler PD.
    Circulation; 1986 Oct 02; 74(4):766-74. PubMed ID: 3019586
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
    Cleland JG, Gillen G, Dargie HJ.
    Eur Heart J; 1988 Feb 02; 9(2):132-41. PubMed ID: 2832173
    [Abstract] [Full Text] [Related]

  • 18. First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril Investigators.
    Lang RM, DiBianco R, Broderick GT, Gottlieb SS, Kostis J, Lyle PA, Makris L, Rajfer SI, Rucinska EJ.
    Am Heart J; 1994 Sep 02; 128(3):551-6. PubMed ID: 8074019
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 02; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.